Back to results
Completed

Identification of Graphic Markers of Neurocognitive Disorders (MG)

NCT05537688

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

CRIUGM

Montreal, Quebec, Canada

View on ClinicalTrials.gov
Identification of Graphic Markers of Neurocognitive Disorders (MG) — TrialFind